132 related articles for article (PubMed ID: 11688091)
1. Stats and facts. Increasing U.S. health research expenditures.
Manag Care Interface; 2001 Oct; 14(10):34-5. PubMed ID: 11688091
[No Abstract] [Full Text] [Related]
2. Is there a federal philosophy about academic medicine.
Fredrickson DS
Bull N Y Acad Med; 1981; 57(6):454-69. PubMed ID: 6941839
[No Abstract] [Full Text] [Related]
3. Reflections on the image of otolaryngology to third-party payers and federal agencies.
Cohn AM
Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1975; 80(2):ORL219-21. PubMed ID: 1129910
[No Abstract] [Full Text] [Related]
4. Advisors may urge NIH to seek out industry support for clinical trials.
Appel A
Nature; 1995 Nov; 378(6553):116. PubMed ID: 7477301
[No Abstract] [Full Text] [Related]
5. The National Institutes of Health Small Business Innovation Research (SBIR) Program: opportunities for orphan drug development.
Engstrom LO
Prog Clin Biol Res; 1985; 197():25-30. PubMed ID: 4070295
[No Abstract] [Full Text] [Related]
6. Prospects for 1987. United States. Health spending still increasing but space science stalled.
Beardsley T; Palca J
Nature; 1987 Jan 1-7; 325(6099):6. PubMed ID: 3099215
[No Abstract] [Full Text] [Related]
7. More research, yes! But what kind?
Myers KJ
J Am Optom Assoc; 1989 Nov; 60(11):815-9. PubMed ID: 2607075
[No Abstract] [Full Text] [Related]
8. An assessment of NHLBI requests for applications.
Roth CA
Physiologist; 1987 Jun; 30(3):35-9. PubMed ID: 3602117
[No Abstract] [Full Text] [Related]
9. Federal support of radiological research.
Hendee WR
Med Instrum; 1981; 15(6):361-4. PubMed ID: 6280024
[TBL] [Abstract][Full Text] [Related]
10. Extramural instrumentation funding by the National Institutes of Health.
Vener KJ
Fed Proc; 1984 Aug; 43(11):2565-71. PubMed ID: 6745446
[No Abstract] [Full Text] [Related]
11. Orphan products development and some methods for maximizing the usefulness of research on rare diseases.
Finkel MJ
Prog Clin Biol Res; 1985; 197():11-8. PubMed ID: 4070285
[No Abstract] [Full Text] [Related]
12. Computerized grants project is unveiled.
Anderson C
Nature; 1991 Apr; 350(6320):646-7. PubMed ID: 2023627
[No Abstract] [Full Text] [Related]
13. Sponsorship of computing research in medicine and biology.
Moraff H
Fed Proc; 1974 Dec; 33(12):2413-4. PubMed ID: 4435252
[No Abstract] [Full Text] [Related]
14. The readers' NIH.
Rosenberg BH
Science; 1992 Oct; 258(5082):530. PubMed ID: 1411553
[No Abstract] [Full Text] [Related]
15. The role of voluntary disease organizations in research and development of orphan drugs.
Horansky R
Prog Clin Biol Res; 1985; 197():179-81. PubMed ID: 4070293
[No Abstract] [Full Text] [Related]
16. Mental retardation research funding trends of the National Institute of Child Health and Human Development.
Baumeister AA; Berkson G
Am J Ment Defic; 1982 Sep; 87(2):119-21. PubMed ID: 7124821
[No Abstract] [Full Text] [Related]
17. The fate of research grant applications on bone and mineral metabolism at the National Institutes of Health.
Novello AC
J Bone Miner Res; 1986 Feb; 1(1):3-4. PubMed ID: 3503530
[No Abstract] [Full Text] [Related]
18. Meeting the real costs of the computer as a research tool in the life sciences.
Davis RM
Fed Proc; 1974 Dec; 33(12):2409-11. PubMed ID: 4435250
[No Abstract] [Full Text] [Related]
19. US Congress adds its voice to the genome-sequencing chorus.
Palca J; Ezzell C
Nature; 1987 Sep 24-30; 329(6137):280. PubMed ID: 3627272
[No Abstract] [Full Text] [Related]
20. Houston breeds biotechnology hot shots.
Gershon D
Nature; 1992 Jun; 357(6380):629. PubMed ID: 1614507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
